Benzinga | Dec 15, 2020 07:08AM EST

Evogene's AgPlenus Announces Reaching A 'Lead' Stage In Novel Mode-Of-Action Herbicide Program

REHOVOT, Israel, Dec. 15, 2020 /PRNewswire/ -- AgPlenus Ltd., an innovative company designing effective, sustainable crop protection products by leveraging computational biology and chemistry, and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), announced today that it has reached the 'Lead' stage in its novel Mode-of-Action (MoA) herbicide program. The achievement of this milestone follows the conclusion of field tests that demonstrated that product candidate APH1, at commercial dose rates, effectively controlled a broad panel of weeds, including weeds that are known to have resistance to existing herbicides. These results were confirmed in independent field tests conducted by SynTech Research, an agricultural R&D contract research organization located in California.